Smoking is the biggest risk factor for non-AIDS-defining cancers in people living with HIV
Varenicline helps people with HIV stop smoking, but success rate remains low
HIV attachment inhibitor BMS-663068 safe and effective in phase 2b study
Deferring hepatitis C treatment can lead to liver cancer and death, despite cure
Study finds high rates of cancer among older people living with HIV
Progression to severe fibrosis or cirrhosis is common among baby boomers with hepatitis C in the US
Levels of maraviroc in vaginal and rectal tissues may not be high enough for pre-exposure prophylaxis
Financial incentives did not improve linkage to care or viral suppression in US study
Tenofovir, boosted atazanavir and boosted lopinavir are associated with cumulative risk of developing chronic kidney disease
Two interferon-free regimens show high HCV cure rates for people with HIV and HCV co-infection
Tenofovir alafenamide equally effective but safer for kidneys and bones than current formulation
Treatment cascades and viral load surveys show how African countries can maximise prevention benefits of HIV treatment
Circumcision is reducing HIV incidence in Uganda, Rakai community study shows
No HIV transmissions from HIV-positive partner seen in Australian gay couples study
US PEPFAR abstinence and faithfulness funding had no impact on sexual behaviour in Africa
HIV maturation inhibitor BMS-955176 looks promising in early study
Starting HIV treatment at CD4 count above 500 reduces the risk of serious illness and death by 44%, African Temprano trial shows
Combining PrEP and ART could almost eliminate HIV infection, east African study finds
